Health Canada just approved memantine (Ebixa) for moderate to severe Alzheimer's disease
February 2005
Health Canada just approved memantine (Ebixa) for moderate to severe Alzheimer's disease.
It's marketed under the brand name Namenda in the U.S.
Until now, there was no specific treatment approved for SEVERE Alzheimer's. The cholinesterase inhibitors (Aricept, Exelon, and Reminyl) are approved for MILD to moderate cases.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive